EXC:NASDAQ

Exelon Corporation

Data as of 2026-03-10 - not real-time

$49.14

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Exelon (EXC) is trading at $49.14, comfortably above its 20‑day SMA of 47.90 and the 50‑day SMA of 45.55, while still below the 200‑day SMA of 44.77, indicating a short‑term bullish bias within a longer‑term upward trend. The RSI sits at 64.7, suggesting momentum is strong but not yet overbought, and the MACD line (1.13) is just above its signal (1.13) with a positive histogram, reinforcing the bullish technical outlook. Support at $43.67 and resistance near $49.88 frame the price, and the current level is flirting with the resistance ceiling, implying limited upside unless a breakout occurs.
Fundamentally, EXC offers an attractive 3.42% dividend yield with a payout ratio of 58.6%, yet free cash flow is negative and debt‑to‑equity is extremely high at 174, raising concerns about dividend sustainability. The stock’s P/E of 18 is below the industry average of 20.8, but the DCF‑derived fair value of $10.65 is far beneath the market price, flagging a potential overvaluation. Recent earnings beat (EPS $0.59 vs. $0.547 estimate) and a modest forward EPS growth to $3.04 provide short‑term earnings momentum, while revenue contraction of 1.1% and a modest ROE of 9.9% temper long‑term growth expectations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA crossover, MACD, RSI)
  • Proximity to resistance limiting immediate upside
  • Strong dividend yield but sustainability concerns

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Consistent dividend payout with attractive yield
  • Earnings beat and stable regulated revenue base
  • High leverage and negative free cash flow raising valuation caution

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF fair value far below market price indicating overvaluation
  • Elevated debt levels and low ROE limiting growth prospects
  • Regulated utility business providing defensive characteristics

Key Metrics & Analysis

Financial Health

Revenue Growth-1.10%
Profit Margin11.41%
P/E Ratio18.0
ROE9.94%
ROA2.84%
Debt/Equity174.49
P/B Ratio1.7
Op. Cash Flow$6.3B
Free Cash Flow$-2124249984
Industry P/E20.8

Technical Analysis

TrendBullish
RSI64.7
Support$43.67
Resistance$49.88
MA 20$47.90
MA 50$45.55
MA 200$44.77
MACDBullish
VolumeStable
Fear & Greed Index78.95

Valuation

Fair Value$10.65
Target Price$50.44
Upside/Downside2.64%
GradeOvervalued
TypeValue
Dividend Yield3.42%

Risk Assessment

Beta-0.04
Volatility24.80%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.